UP-02.131 Irreversible Electroporation (IRE), A Novel Technique for Focal Ablation of Prostate Cancer (PCa): Results of a Interim Pilot Safety Study in Low Risk …

M Brausi, G Giliberto, G Simonini, L Botticelli… - Urology, 2011 - goldjournal.net
Materials and Methods There were 11 patients with PCa enrolled after the Ministry of Health,
Ethical Committee approval and pt signed informed consent. Mean age was 70.2 yrs (range …

V10-08 The use of focal irreversible electroporation for prostate cancer

J Torosyan, A Cherry, H Abbas, S Tayebi… - Journal of …, 2023 - journals.lww.com
METHODS: IRE is performed under general anesthesia with the patient placed in lithotomy
position. Monopolar electrodes are inserted into the prostate under ultrasound guidance and …

Focal therapy using irreversible electroporation: reported successes, with clear limitations, in both primary and salvage settings.

J Fainberg - BJU international, 2023 - search.ebscohost.com
Focal therapy (FT) for prostate cancer, also referred to as partial gland ablation, aims to
reduce prostate cancer treatment morbidity while attaining sufficient oncological control …

Pilot study to assess safety and clinical outcomes of irreversible electroporation for partial gland ablation in men with prostate cancer

KS Murray, B Ehdaie, J Musser, J Mashni… - The Journal of …, 2016 - auajournals.org
Purpose: Partial prostate gland ablation is a strategy to manage localized prostate cancer.
Irreversible electroporation can ablate localized soft tissues. We describe 30 and 90-day …

[PDF][PDF] Quality of life and safety outcomes following irreversible electroporation treatment for prostate cancer: results from a phase I-Ii study

B WVden, DMD Bruin, DP Veelo, AW Postema… - J Cancer Sci …, 2015 - researchgate.net
Objective: Prostate cancer treatment as radical prostatectomy or radiation therapy is
associated with collateral tissue damage resulting inside-effects. Irreversible electroporation …

Focal therapy of prostate cancer index lesion with irreversible electroporation. A prospective study with a median follow-up of 3 years

B Miñana López, G Andrés Boville… - The Journal of …, 2023 - auajournals.org
Purpose: Our aim was to assess oncologic, safety, and quality of life–related outcomes of
focal therapy with irreversible electroporation in men with localized prostate cancer …

RADIATION THERAPY AND IRREVERSIBLE ELECTROPORATION (RTIRE) FOR INTERMEDIATE RISK PROSTATE CANCER: A PHASE II ONGOING TRIAL

LP Calderon, O Strasser, P Abrahimi… - … Oncology: Seminars and …, 2024 - Elsevier
Introduction Radical Prostatectomy (RP), Radiation Therapy (RT) are the standard of care for
patients with intermediate risk prostate cancer (IRPCa). Focal therapy is being increasingly …

Oncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective …

A Blazevski, MJ Scheltema, B Yuen, N Masand… - European urology …, 2020 - Elsevier
Background Focal irreversible electroporation (IRE) can be used to treat men with localised
prostate cancer (PCa) with reduced impact on quality of life (QoL). Objective To assess …

[HTML][HTML] Prostate cancer IRE study (PRIS): a randomized controlled trial comparing focal therapy to radical treatment in localized prostate cancer

A Lantz, P Nordlund, U Falagario, F Jäderling… - European Urology Open …, 2023 - Elsevier
The aim of focal treatments (FTs) in prostate cancer (PCa) is to treat lesions while preserving
surrounding benign tissue and anatomic structures. Irreversible electroporation (IRE) is a …

[HTML][HTML] Evaluation of clinical and mpMRI findings of irreversible electroporation therapy for the treatment of localized prostate cancer: Preliminary results

PG Kızıl, ŞA Altan, NÇ Tarhan… - Turkish journal of urology, 2021 - ncbi.nlm.nih.gov
Objective: To evaluate early clinical and multiparametric prostate magnetic resonance
imaging (mpMRI) results of irreversible electroporation (IRE) efficiency in treatment of …